Biomaterials Advances

Formerly known as Materials Science and Engineering: C, with a 2022 IF of 7.9.

Biomaterials Advances includes topics at the interface of the biomedical sciences and materials engineering. These topics include:

• Bioinspired and biomimetic materials for medical applications

• Materials of biological origin for medical applications

• Materials for "active" medical applications

• Self-assembling and self-healing materials for medical applications

• "Smart" (i.e., stimulus-response) materials for medical applications

• Ceramic, metallic, polymeric, and composite materials for medical applications

• Materials for in vivo sensing

• Materials for in vivo imaging

• Materials for delivery of pharmacologic agents and vaccines

• Novel approaches for characterizing and modeling materials for medical applications

Manuscripts on biological topics without a materials science component, or manuscripts on materials science without biological applications, will not be considered for publication in Biomaterials Advances. New submissions are first assessed for language, scope and originality (plagiarism check) and can be desk rejected before review if they need English language improvements, are out of scope or present excessive duplication with published sources.

Biomaterials Advances sits within Elsevier's biomaterials science portfolio alongside Biomaterials, Materials Today Bio and Biomaterials and Biosystems. As part of the broader Materials Today family, Biomaterials Advances offers authors rigorous peer review, rapid decisions, and high visibility. We look forward to receiving your submissions!